Pracinostat (SB939)
Potent and oral inhibitor of histone deacetylase (HDAC), selective for class I, II and IV HDACs. SB939 shows significant antiproliferative activity against a wide variety of tumor cell lines, with high tumor exposure and efficacy in mouse models of colorectal cancer.
Product Specifications
Background
Pracinostat (SB939) is an orally bioavailable, small-molecule histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. Pracinostat inhibits HDACs, which may result in the accumulation of highly acetylated histones. It is a pan-HDAC inhibitor, inhibiting all HDAC isozymes except HDAC6 and HDAC7.
CAS Number
929016-96-6
Solubility
Soluble in DMSO
Molecular Formula
C20H30N4O2
Shipping Conditions
Room Temperature (continental US) or Gel Packs
Storage Conditions
Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Calculated Molecular Weight
358.48 Da
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![ERK1 (T207) /ERK2 (T188) [conserved], Phosphospecific Antibody](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6224278-01 0.1 mL
REXO2 (RNA Exonuclease 2 Homolog, REX2, CGI-114, Oligoribonuclease, Mitochondrial, RFN, Small Fragment Nuclease, SFN, SMFN) (MaxLight 650)
Ask
View Details MBS6224278-02 5x 0.1 mL
REXO2 (RNA Exonuclease 2 Homolog, REX2, CGI-114, Oligoribonuclease, Mitochondrial, RFN, Small Fragment Nuclease, SFN, SMFN) (MaxLight 650)
Ask
View Details